Skip To Main Content
Michael Bartkoski on Muck Rack

Michael Bartkoski

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GLP‐1 Agonists for Pediatric Psychopharmacology: Opportunities and Cautions

|
By Therapeutic Innovation, Ethan A. Poweleit, Stephani Stancil, Michael Bartkoski
| Wiley Online Library Verified
ADHD attention-deficit hyperactivity disorder GABA gamma-aminobutyric acid GLP-1 glucagon-like peptide-1 GLP-1As GLP-1 agonists NCT National Clinical Trial T2DM type 2 diabetes mellitus Glucagon-like peptide-1 agonists (GLP-1A), approved for pediatric obesity and type 2 diabetes mellitus (T2DM), are gaining attention for potential psychiatric benefits, including modulating dietary behaviors, reducing substance use, improving mood, and curbing binge eating.
Open in Who Shared Issue with article?
See all 1 articles